KSS heads into its May 20 Q1 earnings with one of the highest short positions in US retail, a stock down nearly 10% on the week, and a Street that sees limited recovery potential.
Short interest is the dominant story here. With 26.7% of the free float sold short, Kohl's carries a short burden that few large retailers match. That position has climbed roughly 15% over the past month, rising from around 25% in mid-March to just under 27% now — a steady accumulation, not a spike. The ORTEX short score of 65.4 ranks in just the 9th percentile of the universe on short score rank, flagging Kohl's as a heavily watched name on the bearish side. Borrow conditions, however, offer no sign of a squeeze: cost to borrow is barely above 0.5% and has drifted lower over the past month, while availability in the lending market remains comfortable. There is no shortage of supply for new shorts who want to add.
Options traders have shifted notably more bullish in recent sessions, which cuts against the short-heavy picture. The put/call ratio has dropped to 0.86, about 1.3 standard deviations below its 20-day average of 1.00. That's a meaningful rotation — for most of April, the PCR ran well above 1.0, reflecting consistent demand for downside protection. The move lower in the ratio suggests either put-holders are closing hedges or call activity is picking up, even as the stock lost 5.6% on Wednesday alone.
The Street reads this as a structural story, not a temporary setback. Following the March 10 earnings release — which sent the stock down 6.8% on the day and nearly 14.3% over the subsequent five sessions — analysts broadly trimmed targets rather than their ratings. Goldman Sachs holds a Sell with a $13 target, essentially at the current price. BofA cut to $15 from $18 with an Underperform. JPMorgan lowered to $15 from $22, keeping Underweight. The consensus is Hold, but with seven analysts neutral and several influential names sitting at Sell, the path to a constructive re-rating looks narrow. The average analyst target of roughly $14.83 sits only marginally above Wednesday's close of $13.98, leaving little buffer. Bulls point to Kohl's store footprint across 49 states and improving private-label mix. Bears argue the core low-to-middle-income customer is under pressure and that online competition is eroding the moderate-pricing strategy that has historically driven traffic.
Institutional holders added modestly into Q1. BlackRock, the largest holder at 17.8% of shares, added around 1.2 million shares in the quarter to March 31. Dimensional Fund Advisors added 744,000 shares, and American Century added 361,000. Fuller & Thaler entered as a new position of roughly 2.4 million shares as of February. On the other side, Morgan Stanley trimmed by 1.84 million shares through year-end 2025. The 90-day insider net activity shows marginal net buying of about 70,000 shares, though the actual transactions are small — mostly sell-to-cover events from the HR Director and scattered C-suite sells at $12.90–$13.51. No executive has been buying in size. The dividend, last paid in mid-2022 at $0.50 per share, was suspended thereafter; the dividend score of 96 from ORTEX's factor model appears to reflect historical yield data and should be treated with caution given the lapsed payment history.
Earnings reactions have been consistently negative. The last three results events all produced losses — down 4.4% and 6.8% on the day respectively, with the five-day window extending those declines to 6.8% and 14.3%. The one outlier was November 2025, when the stock jumped 53% on the day, likely on news that moved the restructuring narrative. But the subsequent earnings in March 2026 reversed that goodwill quickly.
With the May 20 print now three weeks away, the key tension is whether the stock can hold near current levels given the weight of short interest, a cautious Street, and a PCR that has just turned more optimistic. Peer M fell 4.5% on the week and DDS dropped 7.7%, so the sector backdrop is broadly soft. What to watch: whether short interest continues its slow monthly grind higher, and whether the options market's newfound relative optimism proves prescient or simply fades before the Q1 release.
See the live data behind this article on ORTEX.
Open KSS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
